Benítez-Cano Adela, Bermejo Silvia, Luque Sonia, Sorlí Luisa, Carazo Jesús, Zaragoza Irene, Ramos Isabel, Vallès Jordi, Horcajada Juan P, Adalia Ramón
Department of Anesthesiology and Surgical Intensive Care, Hospital del Mar, Parc de Salut Mar, 08003 Barcelona, Spain.
Infectious Pathology and Antimicrobial Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
J Pers Med. 2023 Oct 11;13(10):1482. doi: 10.3390/jpm13101482.
Respiratory infections are frequent and life-threatening complications of surgery. This study aimed to evaluate the clinical, microbiological and treatment characteristics of severe postoperative pneumonia (POP) and tracheobronchitis (POT) in a large series of patients. This single-center, prospective observational cohort study included patients with POP or POT requiring intensive care unit admission in the past 10 years. We recorded demographic, clinical, microbiological and therapeutic data. A total of 207 patients were included, and 152 (73%) were men. The mean (SD) age was 70 (13) years and the mean (SD) ARISCAT score was 46 (19). Ventilator-associated pneumonia was reported in 21 patients (10%), hospital-acquired pneumonia was reported in 132 (64%) and tracheobronchitis was reported in 54 (26%). The mean (SD) number of days from surgery to POP/POT diagnosis was 6 (4). The mean (SD) SOFA score was 5 (3). Respiratory microbiological sampling was performed in 201 patients (97%). A total of 177 organisms were cultured in 130 (63%) patients, with a high proportion of Gram-negative and multi-drug resistant (MDR) bacteria (20%). The most common empirical antibiotic therapy was a triple-drug regimen covering MDR Gram-negative bacteria and MRSA. In conclusion, surgical patients are a high-risk population with a high proportion of early onset severe POP/POT and nosocomial bacteria isolation.
呼吸道感染是手术常见且危及生命的并发症。本研究旨在评估大量患者中严重术后肺炎(POP)和气管支气管炎(POT)的临床、微生物学及治疗特征。这项单中心前瞻性观察队列研究纳入了过去10年中因POP或POT需要入住重症监护病房的患者。我们记录了人口统计学、临床、微生物学及治疗数据。共纳入207例患者,其中152例(73%)为男性。平均(标准差)年龄为70(13)岁,平均(标准差)ARISCAT评分为46(19)。21例患者(10%)报告发生呼吸机相关性肺炎,132例(64%)报告发生医院获得性肺炎,54例(26%)报告发生气管支气管炎。从手术到POP/POT诊断的平均(标准差)天数为6(4)天。平均(标准差)序贯器官衰竭评估(SOFA)评分为5(3)。201例患者(97%)进行了呼吸道微生物采样。130例(63%)患者共培养出177种微生物,革兰阴性菌和多重耐药(MDR)菌比例较高(20%)。最常见的经验性抗生素治疗是覆盖MDR革兰阴性菌和耐甲氧西林金黄色葡萄球菌(MRSA)的三联药物方案。总之,手术患者是高危人群,早期发生严重POP/POT及医院内细菌分离的比例较高。